CompaniesCerebral Therapeutics

Cerebral Therapeutics

defunct

About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (4)

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

68

By Phase

EARLY_PHASE1: 1PHASE1/PHASE2: 2PHASE2: 1

By Status

TERMINATED: 2NOT_YET_RECRUITING: 1COMPLETED: 1

Clinical Trials Pipeline4 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Today

Hover over trial bars to see details

Recent Trials

NCT04971798Lead Sponsor

Cell-free Stem Cell-derived Extract Formulation for Knee Osteoarthritis

EARLY_PHASE1Not yet recruiting

12 participants

Started: Jan 1, 2023 · Completed: Dec 31, 2025

NCT04529954Lead Sponsor

Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion

PHASE1/PHASE2Terminated

20 participants

Started: Jan 1, 2021 · Completed: Mar 1, 2024

NCT04153175Lead Sponsor

Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization

PHASE2Terminated

30 participants

Started: Aug 21, 2020 · Completed: Mar 1, 2024

NCT02899611Lead Sponsor

A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures

PHASE1/PHASE2Completed

Started: Aug 31, 2016 · Completed: Jun 1, 2021

Funding History (4)

D

Jan 17, 2020

D/A

Mar 20, 2019

D/A

Jun 27, 2018

D

Jun 25, 2018